Advanced search
Publication Cover
Gynecological Endocrinology Volume 27, 2011 - Issue 1
Submit an article Journal homepage
257
Views
8
CrossRef citations to date
0
Altmetric
PCOS

Polycystic ovary syndrome or hyperprolactinaemia: a study of mild hyperprolactinaemia

Hung-wen SuDepartment of Obstetrics and Gynecology, Taipei Medical University, Wan-Fang Hospital, Taipei, Taiwan
,
Ching-min ChenSchool of Geriatric Nursing and Care Management, College of Nursing, Taipei Medical University, Taipei, Taiwan
,
Szu-yuan ChouDepartment of Obstetrics and Gynecology, Taipei Medical University, Wan-Fang Hospital, Taipei, Taiwan
,
So-jung LiangDepartment of Obstetrics and Gynecology, Taipei Medical University, Wan-Fang Hospital, Taipei, Taiwan
,
Chun-sen HsuDepartment of Obstetrics and Gynecology, Taipei Medical University, Wan-Fang Hospital, Taipei, Taiwan
&
Ming-i HsuDepartment of Obstetrics and Gynecology, Taipei Medical University, Wan-Fang Hospital, Taipei, TaiwanCorrespondence[email protected]
Pages 55-62 | Received 21 Dec 2009, Accepted 16 Apr 2010, Published online: 26 May 2010

References

  • Practice Committee of American Society for Reproductive Medicine. Current evaluation of amenorrhea. Fertil Steril 2008;90:S219–S225.
  • Abbott DH, Barnett DK, Bruns CM, Dumesic DA. Androgen excess fetal programming of female reproduction: a developmental aetiology for polycystic ovary syndrome? Hum Reprod Update 2005;11:357–374.
  • Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004;81:19–25.
  • Mah PM, Webster J. Hyperprolactinemia: etiology, diagnosis, and management. Semin Reprod Med 2002;20:365–374.
  • Isik AZ, Gulekli B, Zorlu CG, Ergin T, Gokmen O. Endocrinological and clinical analysis of hyperprolactinemic patients with and without ultrasonically diagnosed polycystic ovarian changes. Gynecol Obstet Invest 1997;43:183–185.
  • Corenblum B, Taylor PJ. The hyperprolactinemic polycystic ovary syndrome may not be an distinct entity. Fertil Steril 1982;38:549–552.
  • Falaschi P, del Pozo E, Rocco A, Toscano V, Petrangeli E, Pompei P, Frajese G. Prolactin release in polycystic ovary. Obstet Gynecol 1980;55:579–582.
  • Papaleo E, Doldi N, De Santis L, Marelli G, Marsiglio E, Rofena S, et al, Cabergoline influences ovarian stimulation in hyperprolactinaemic patients with polycystic ovary syndrome. Hum Reprod 2001;16:2263–2266.
  • Filho RB, Domingues L, Naves L, Ferraz E, Alves A, Casulari LA. Polycystic ovary syndrome and hyperprolactinemia are distinct entities. Gynecol Endocrinol 2007;23:267–272.
  • Prelević GM, Würzburger MI, Perić LA. Acute effects of L-dopa and bromocriptine on serum PRL, LH and FSH levels in patients with hyperprolactinemic and normoprolactinemic polycystic ovary syndrome. J Endocrinol Invest 1987;10:389–395.
  • Bracero N, Zacur HA. Polycystic ovary syndrome and hyperprolactinemia. Obstet Gynecol Clin North Am 2001;28:77–84.
  • Tsutsumi R, Webster NJ. GnRH pulsatility, the pituitary response and reproductive dysfunction. Endocr J 2009;56:729–737.
  • Taylor AE. Gonadotropin dysfunction in women with polycystic ovary syndrome. Fertil Steril 2006;86 (Suppl 1):S12.
  • Hsu MI, Liou TH, Liang SJ, Su HW, Wu CH, Hsu CS. Inappropriate gonadotropin secretion in polycystic ovary syndrome. Fertil Steril 2009;91:1168–1174.
  • Zawadski JK, Dunaif A. Diagnostic criteria for polycystic ovary syndrome; towards a rational approach. In: Dunaif A, Givens JR, Haseltine F, editors. Polycystic ovary syndrome. Boston: Blackwell Scientific; 1992. pp 377–384.
  • Committee S. The Asia-Pacific perspective: redefining obesity and its treatment. Melbourne: International Diabetes Institute; 2000.
  • Hattori N. Macroprolactinemia: a new cause of hyperprolactinemia. J Pharmacol Sci 2003;92:171–177.
  • Verhelst J, Abs R. Hyperprolactinemia: pathophysiology and management. Treat Endocrinol 2003;2:23–32.
  • Paoletti AM, Cagnacci A, Soldani R, Orrù M, Ajossa S, Pittorra G, et al Evidence that an altered prolactin release is consequent to abnormal ovarian activity in polycystic ovary syndrome. Fertil Steril 1995;64:1094–1098.
  • Blank SK, McCartney CR, Marshall JC. The origins and sequelae of abnormal neuroendocrine function in polycystic ovary syndrome. Hum Reprod Update 2006;12:351–361.
  • Tay CC, Glasier AF, Illingworth PJ, Baird DT. Abnormal twenty-four hour pattern of pulsatile luteinizing hormone secretion and the response to naloxone in women with hyperprolactinaemic amenorrhoea. Clin Endocrinol (Oxf) 1993;39:599–606.
  • Hernández I, Parra A, Méndez I, Cabrera V, Cravioto MC, Mercado M, et al Hypothalamic dopaminergic tone and prolactin bioactivity in women with polycystic ovary syndrome. Arch Med Res 2000;31:216–222.
  • Luciano AA, Chapler FK, Sherman BM. Hyperprolactinemia in polycystic ovary syndrome. Fertil Steril 1984;41:719–725.
  • Liou TH, Yang JH, Hsieh CH, Lee CY, Hsu CS, Hsu MI. Clinical and biochemical presentations of polycystic ovary syndrome among obese and nonobese women. Fertil Steril 2009;92:1960–1965.
  • Arroyo A, Laughlin GA, Morales AJ, Yen SS. Inappropriate gonadotropin secretion in polycystic ovary syndrome: influence of adiposity. J Clin Endocrinol Metab 1997;82:3728–3733.
  • Taylor AE, McCourt B, Martin KA, Anderson EJ, Adams JM, Schoenfeld D, et al Determinants of abnormal gonadotropin secretion in clinically defined women with polycystic ovary syndrome. J Clin Endocrinol Metab 1997;82:2248–2256.
  • Pagan YL, Srouji SS, Jimenez Y, Emerson A, Gill S, Hall JE. Inverse relationship between luteinizing hormone and body mass index in polycystic ovarian syndrome: investigation of hypothalamic and pituitary contributions. J Clin Endocrinol Metab 2006;91:1309–1316.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.